Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
PFIZER Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
High and improving ROE
High and improving operating margin
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
PFIZER Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
PFIZER Bulk, Block & Insider Trades
PFIZER Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Others
Bonus(1 new shares for 1 existing shares) Ex-date: 14th Jun 2000 Announced on: 14th Mar 2000
MergerEquity shares issued to the shareholders of erstwhile Parke-Davis (India) Ltd. pursuant to the Scheme of Amalgamation with the company. Ex-date: 10th Sep 2003 Announced on: 10th Sep 2003
Company Profile
Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approve... Read More
Key personnel
Dr. Pradip Panalal Shah, Ph.D.D
Non-Executive Non-Independent Chairman of the Board
Mr. Amit AgarwalD
Chief Financial Officer, Executive Director - Finance
Mrs. Meenakshi NevatiaD
Managing Director, Executive Director
Mr. Sharad Goswami
Senior Director - Policy and Public Affairs
Dr. Pankaj Gupta
Senior Director - Medical Affairs
Dr. Manish Paliwal
Senior Director - Regulatory Affairs
Mr. Anil Pattanshetty
Senior Director - Business Operations
Mr. Pazhania Pillai RenganD
Executive Director - Plant Operations
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Pfizer Ltd.?
The current share price of Pfizer Ltd. is ₹ 4,871.77 as of 09 Jan 2026.
What is the PE ratio of Pfizer Ltd.?
The Price-to-Earnings (PE) ratio of Pfizer Ltd. is 26.55 as of the latest financial data.
What is the ROE and ROCE of Pfizer Ltd.?
Pfizer Ltd. has a Return on Equity (ROE) of 22.09% and a Return on Capital Employed (ROCE) of 19.34% as per the latest financial reports.
What is the market cap of Pfizer Ltd.?
The market capitalization of Pfizer Ltd. stands at ₹ 22,287.40 Cr.
What is the dividend yield of Pfizer Ltd.?
The dividend yield of Pfizer Ltd. is 0.72% based on the current market price.
What is the RSI of Pfizer Ltd.?
The Relative Strength Index (RSI) of Pfizer Ltd. is 40.64.
What is the FII and DII holding in Pfizer Ltd.?
Foreign Institutional Investors (FII) hold 2.60% and Domestic Institutional Investors (DII) hold 17.11% of Pfizer Ltd. shares.
What sector does Pfizer Ltd. belong to?
Pfizer Ltd. operates in the Healthcare sector.
What is the beta of Pfizer Ltd. stock?
The beta of Pfizer Ltd. stock is 0.34, indicating its volatility relative to the broader market.
